Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Insulin lispro protamine is an intermediate- to long-acting insulin analog. It is designed to provide basal insulin coverage, helping to control blood glucose levels between meals and overnight. It is frequently studied and used in the management of both type 1 and type 2 diabetes, and its efficacy and safety have also been evaluated in pregnant women with diabetes. The drug is often formulated as a suspension and can be found in premixed preparations with insulin lispro.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on insulin lispro protamine.